Sidley Helps Takeda With $800M Gout Drugmaker Buy

Law360, New York (April 11, 2012, 12:07 PM EDT) -- A unit of Japanese drug company Takeda Pharmaceutical Co. Ltd. plans to scoop up URL Pharma Inc., a privately owned Philadelphia-based manufacturer of gout medicines, for at least $800 million in cash up front, the subsidiary announced Wednesday.

Per the deal, URL Pharma’s current owners could also earn more capital if the company hits certain performance benchmarks starting in 2015. The gout treatment company is being bought by Takeda America Holdings Inc. Upon completion of the transaction, it will be managed by Takeda Pharmaceuticals USA Inc.,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.